APOLLOHOSP8,894.00

Apollo Hospitals Enterprise Ltd.

· Pharma & Health
₹ CrorePeersFORTISMAXHEALTHMEDANTASUNPHARMACIPLADRREDDYDIVISLABTORNTPHARMMcap ₹1.28L Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation687.0757.5876.1
+ Impairment Loss / (Reversal)0.02.00.0
+ Finance Costs449.4458.5449.6
+ Interest Income-42.9-92.4-74.0
+ Dividend Income0.0-0.7-2.7
+ Fair Value (Gains) / Losses-30.3-63.4-62.1
+ Share-based Payments87.5112.7158.9
+ Unrealised FX (Gain) / Loss0.10.1-0.2
+ Other Non-cash Items71.862.90.0
+ Other — Cash Effects are Investing / Financing-5.4-6.9-14.8
+ Other Reconciling Items0.00.088.7
Changes in Working Capital
+ Inventories-69.2-21.0-61.1
+ Trade Receivables — Current-335.2-564.2-553.3
+ Other Financial Assets — Current-16.00.00.0
+ Other Financial Assets — Non-current-221.25.2-177.3
+ Other Current Assets-22.60.021.4
+ Other Non-current Assets23.3-14.50.0
+ Trade Payables — Current410.8-128.08.6
+ Other Financial Liabilities — Current614.00.0135.6
+ Other Financial Liabilities — Non-current-605.843.80.0
+ Other Current Liabilities-2.10.039.9
+ Other Non-current Liabilities-1.926.40.0
+ Provisions — Current33.246.012.1
Cash from Operating Activities
Profit Before Tax (per I/S)1,362.52,006.12,616.02,832.3
+ Total Adjustments (incl. Working Capital)1,024.5624.0845.4
Cash from Operations (pre-tax)2,387.02,630.13,461.4
+ Income Taxes Paid466.7493.7605.7
Cash from Operating Activities1,920.32,136.42,855.7
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)1,136.81,712.71,962.0
+ Disp of Fixed Assets1.914.931.1
+ Acq of Other Long-term Assets1,171.10.00.0
+ Disp of Other Long-term Assets816.70.00.0
+ Purchase of Investments (Equity / Debt)0.03,217.66.9
+ Sale of Investments (Equity / Debt)0.01,815.10.3
+ Acq of Subsidiaries / Businesses (net)3.70.01,300.3
+ Loans & Advances Made14.029.112.5
+ Loans & Advances Repaid16.58.426.8
+ Dividends Received — Investing0.09.811.8
+ Interest Received — Investing39.384.484.3
+ Other Inflows / (Outflows) — Investing-85.9-353.8979.2
Cash from Investing Activities-1,537.1-3,380.6-2,148.2
Cash from Financing Activities
+ Proceeds from Issue of Shares2.445.90.0
+ Proceeds from Other Equity Instruments0.00.02.6
+ Payments — Change in Ownership of Subsidiaries14.42.40.0
+ Proceeds from Borrowings707.42,551.11,114.9
+ Repayment of Borrowings253.9442.2734.0
+ Payment of Lease Liabilities0.0256.3290.7
+ Payment of Finance Lease Liabilities228.9
+ Interest Paid302.9301.9277.6
+ Dividends Paid220.9278.4292.8
+ Other Inflows / (Outflows) — Financing0.01.00.0
Cash from Financing Activities-311.21,316.8-477.6
Net Changes in Cash (pre-FX)72.072.6229.9
Net Changes in Cash72.072.6229.9
Closing Cash72.0578.1
Reference Items
EBITDA2,390.73,021.83,769.34,009.5
EBITDA Margin %12.5413.8714.9415.17
Free Cash Flow (CFO − Capex)783.5423.7893.7893.7
Free Cash Flow to Equity2,235.1999.4
Free Cash Flow per Basic Share54.4929.4662.1562.15
Price to Free Cash Flow143.11
Cash Flow to Net Income2.051.421.43
Cash Paid for Taxes466.7493.7605.7
Cash Paid for Interest302.9301.9277.6
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 146%.